GSK licenses stable cell line technology to Orchard – FirstWord Pharma

GSK licenses stable cell line technology to Orchard - FirstWord Pharma

Frost & Sullivan IDs Five New Technologies to Power Research Across...

Frost & Sullivan IDs Five New Technologies to Power Research Across Preclinical Disease Models

Tonix Pharmaceuticals Holding Corp. Closes $10.5 Million Common Stock Registered Direct...

Tonix Pharmaceuticals Holding Corp. Closes $10.5 Million Common Stock Registered Direct Offering Nasdaq:TNXP

RIBOMIC Announces Dosing of First Subject in RBM-007 Phase 1 Clinical...

RIBOMIC Announces Dosing of First Subject in RBM-007 Phase 1 Clinical Trial for Achondroplasia

Can-Fite Completes Phase II COVID-19 Protocol Based on FDA Guidance, Plans...

Can-Fite Completes Phase II COVID-19 Protocol Based on FDA Guidance, Plans to File IND Shortly
- Advertisement -

LATEST NEWS

MUST READ